Ophthalmology

By Kelsey Kaustinen

Taking aim at Bcl-xL

Scientists identify a new target for treating age-related eye diseases
By DDNews Staff

A hope for fewer injections

Roche's faricimab injected every 16 weeks proves non-inferior to aflibercept injected every eight weeks in patients with “wet” age-related macular degeneration
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

September 2022

Latest Issue  

• Volume 18 • Issue 9 • September 2022

September 2022

September 2022